Frankfurt , Dec 20, 2014 – German drugmaker Bayer said on Wednesday it had entered into a definitive agreement to sell veterinary products to treat horses to Sanofi’s animal health unit Merial.
The deal to sell these products – Legend/Hyonate and Marquis – is expected to close in the first quarter, subject to merger control clearance, it said, without providing financial details.
“These equine products have no strategic relevance for our business and represent less than 2 percent of our worldwide sales,” said Dirk Ehle, head of Bayer HealthCare’s Animal Health Division. Reuters
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…